Oxford Asset Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Oxford Asset Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-34,655	Closed	-$34K	–	2121
2019 Q1	$34K	Sell	34,655 -27,530	-44%	-$29.6K	﹤0.01%	1609
2018 Q4	$52K	Buy	+62,185	New	+$122K	﹤0.01%	1702
2018 Q1	–	Sell	-24,065	Closed	-$55K	–	2092
2017 Q4	$55K	Buy	+24,065	New	+$52.4K	﹤0.01%	1553
2017 Q1	–	Sell	-175,198	Closed	-$491K	–	1579
2016 Q4	$491K	Buy	+175,198	New	+$496K	0.02%	589

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Oxford Asset Management's SPHS Position: Q2 2019 in Review

Oxford Asset Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 34,655 shares — an estimated $34K sold.

Oxford Asset Management first reported a position in SPHS in Q4 2016 and held it in 4 quarters. The position peaked at $491K in Q4 2016. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

Oxford Asset Management reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 34,655 Sophiris Bio, Inc. shares in Q2 2019, an estimated $34K.
Oxford Asset Management first reported a position in Sophiris Bio, Inc. in Q4 2016 and held it in 4 quarters.
Oxford Asset Management's Sophiris Bio, Inc. position peaked at $491K in Q4 2016.
22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.